GlaxoSmithKline, CureVac to make COVID-19 vaccines aimed at new variants

Virus Outbreak Germany Vaccine

Drugmaker GlaxoSmithKline says it will work with German biopharmaceutical company CureVac to develop new vaccines targeting emerging variants of coronavirus. The announcement comes amid concerns that some mutations are making the virus harder to combat COVID-19.

More From Author

U.S. technology company Clearview AI violated Canadian privacy law: report

How the Black Canadian Coaches Association was born from George Floyd’s death

Canada Household Products

Canada Household Products

Canada Household Products

Canada Cooking Recipe Listings

Canada Recipe Listings

Canada Cookbook Recipes For Beginners #3

Canada Cookbook Recipes For Beginners #4